BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29131521)

  • 21. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-Wide Network-Based Analysis of Colorectal Cancer Identifies Novel Prognostic Factors and an Integrative Prognostic Index.
    Hou X; He X; Wang K; Hou N; Fu J; Jia G; Zuo X; Xiong H; Pang M
    Cell Physiol Biochem; 2018; 49(5):1703-1716. PubMed ID: 30248669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
    Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
    Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
    Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
    World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    Kozman MA; Fisher OM; Rebolledo BJ; Parikh R; Valle SJ; Arrowaili A; Alzahrani N; Liauw W; Morris DL
    J Surg Oncol; 2018 Mar; 117(4):725-736. PubMed ID: 29266235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
    Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
    Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
    Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel.
    Björkman K; Jalkanen S; Salmi M; Mustonen H; Kaprio T; Kekki H; Pettersson K; Böckelman C; Haglund C
    Sci Rep; 2021 Feb; 11(1):4287. PubMed ID: 33619304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.
    Li Destri G; Rubino AS; Latino R; Giannone F; Lanteri R; Scilletta B; Di Cataldo A
    Int Surg; 2015 Apr; 100(4):617-25. PubMed ID: 25875542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of the detection of peripheral blood CEACAM5mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer.
    Vardakis N; Messaritakis I; Papadaki C; Agoglossakis G; Sfakianaki M; Saridaki Z; Apostolaki S; Koutroubakis I; Perraki M; Hatzidaki D; Mavroudis D; Georgoulias V; Souglakos J
    Clin Cancer Res; 2011 Jan; 17(1):165-73. PubMed ID: 21071514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
    Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
    Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients.
    Xia Y; Wang D; Zhang N; Wang Z; Pang L
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28543924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
    Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S
    J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection.
    Li Q; Dai W; Li Y; Xu Y; Li X; Cai S
    Sci Rep; 2017 Apr; 7():46345. PubMed ID: 28417967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
    Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
    Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.